Your browser doesn't support javascript.
loading
Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma.
Evans, Jessica L; Vidri, Roberto J; MacGillivray, Dougald C; Fitzgerald, Timothy L.
Afiliação
  • Evans JL; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland.
  • Vidri RJ; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland; St. Mary's Regional Medical Center, Surgery, Lewiston, ME.
  • MacGillivray DC; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland.
  • Fitzgerald TL; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland. Electronic address: tlfitzgera@mmc.org.
Surgery ; 164(3): 589-593, 2018 09.
Article em En | MEDLINE | ID: mdl-29929753

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma / Mitose Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma / Mitose Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article